Capsule Biopsy in Acellular Dermal Matrix-based Prosthetic Breast Reconstruction: a Prospective Pilot Study
1 other identifier
interventional
N/A
1 country
1
Brief Summary
In this prospective study, breast capsule biopsy was performed in patients undergoing 2-stage expander-implant breast reconstruction to determine its use. Prospective clinical trial was designed for 10 consecutive patients as a pilot study and approved by IRB of Samsung Medical Center. From November 2013 to May 2015, full-thickness capsule biopsy specimen was obtained from acellular dermal matrix (ADM) capsule and from native subpectoral capsule (internal control) during expander-implant exchange. Biopsy specimens were scored for fibrosis and inflammatory reactions. This is completed study and its specific title, study objective, method, and results will be available online after scientific journal submission.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 3, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 26, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 26, 2015
CompletedFirst Submitted
Initial submission to the registry
November 14, 2018
CompletedFirst Posted
Study publicly available on registry
November 16, 2018
CompletedNovember 19, 2018
November 1, 2018
1.6 years
November 14, 2018
November 15, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
histology scoring
semiquantitative histopathologic score system of biopsy specimens (reference: Basu et al., Plastic and Reconstructive Surgery, 126: 1842, 2010)
immediate after biopsy
Interventions
Eligibility Criteria
You may qualify if:
- age between 20 and 70
- planning 2-stage expander-implant breast reconstruction using acellular dermal matrix
- with no medical history such as diabetes, hypertension, or smoking
- no surgical history
You may not qualify if:
- pregnant
- newly detected medical or surgical condition
- acellular dermal matrix loss due to allergic reaction or prosthetic infection
- breast cancer recurrence
- transfer to other institution
- reconstruction give-up due to patient's wish
- no biopsy score
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samsung Medical Center
Seoul, 06351, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jai-Kyong Pyon, MD,PhD
Samsung Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Principal Investigator
Study Record Dates
First Submitted
November 14, 2018
First Posted
November 16, 2018
Study Start
November 3, 2013
Primary Completion
May 26, 2015
Study Completion
May 26, 2015
Last Updated
November 19, 2018
Record last verified: 2018-11